196 related articles for article (PubMed ID: 15046232)
41. Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography.
Sears RJ; Duckworth CW; Decaestecker C; Bourgeois N; Ledent T; Deviere J; Salmon I; Kiss R; Yeaton P
Cancer; 1998 Apr; 84(2):119-26. PubMed ID: 9570216
[TBL] [Abstract][Full Text] [Related]
42. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor.
Stathopoulos G; Nourmand AD; Blackstone M; Andersen D; Baker AL
J Clin Gastroenterol; 1995 Sep; 21(2):143-8. PubMed ID: 8583081
[TBL] [Abstract][Full Text] [Related]
43. [Autoimmune pancreatitis and IgG-positive sclerosing cholangitis].
Díte P; Novotný I; Lata J; Růzicka M; Geryk E; Kianicka B
Vnitr Lek; 2011 Mar; 57(3):254-7. PubMed ID: 21495406
[TBL] [Abstract][Full Text] [Related]
44. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
Azeem N; Gostout CJ; Knipschield M; Baron TH
Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
[TBL] [Abstract][Full Text] [Related]
45. Concurrent primary sclerosing cholangitis and eosinophilic colitis.
Gunji N; Katakura K; Takahashi A; Fujiwara T; Suzuki R; Watanabe H; Ohira H
Intern Med; 2014; 53(20):2319-24. PubMed ID: 25318795
[TBL] [Abstract][Full Text] [Related]
46. Primary sclerosing cholangitis.
Williamson KD; Chapman RW
Dig Dis; 2014; 32(4):438-45. PubMed ID: 24969292
[TBL] [Abstract][Full Text] [Related]
47. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis.
Tokala A; Khalili K; Menezes R; Hirschfield G; Jhaveri KS
AJR Am J Roentgenol; 2014 Mar; 202(3):536-43. PubMed ID: 24555589
[TBL] [Abstract][Full Text] [Related]
48. Primary sclerosing cholangitis associated with autoimmune pancreatitis.
Ichimura T; Kondo S; Ambo Y; Hirano S; Ohmi M; Okushiba S; Morikawa T; Shimizu M; Katoh H
Hepatogastroenterology; 2002; 49(47):1221-4. PubMed ID: 12239909
[TBL] [Abstract][Full Text] [Related]
49. Definition and pathology of primary sclerosing cholangitis.
Nakanuma Y; Harada K; Katayanagi K; Tsuneyama K; Sasaki M
J Hepatobiliary Pancreat Surg; 1999; 6(4):333-42. PubMed ID: 10664278
[TBL] [Abstract][Full Text] [Related]
50. Does an isolated benign choledochal stricture hide a PSC?
De Angelis P; Tambucci R; Romeo E; Rea F; Caloisi C; Caldaro T; di Abriola GF; Foschia F; Torroni F; Monti L; Dall'Oglio L
J Pediatr Surg; 2013 May; 48(5):1006-11. PubMed ID: 23701774
[TBL] [Abstract][Full Text] [Related]
51. Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Waldthaler A; Schramm C; Bergquist A
Eur J Med Genet; 2021 Jun; 64(6):104231. PubMed ID: 33905896
[TBL] [Abstract][Full Text] [Related]
52. Primary sclerosing cholangitis: diagnostic and therapeutic problems.
Gotthardt D; Chahoud F; Sauer P
Dig Dis; 2011; 29 Suppl 1():41-5. PubMed ID: 22104752
[TBL] [Abstract][Full Text] [Related]
53. Primary sclerosing cholangitis.
Milkiewicz P; Wunsch E
Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
[TBL] [Abstract][Full Text] [Related]
54. IgG4 Sclerosing Cholangitis - an Inflammation Imitating Tumour of the Pancreas and Biliary Tract.
Peňázová P; Andrašina T; Novotný I; Trna J; Hemmelová B; Kunovsky L; Procházka V; Kala Z
Klin Onkol; 2019; 32(2):143-151. PubMed ID: 30995856
[TBL] [Abstract][Full Text] [Related]
55. Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis.
Piccolboni P; Ragone E; Inzirillo A; Utili R
G Chir; 2013; 34(9-10):267-70. PubMed ID: 24629813
[TBL] [Abstract][Full Text] [Related]
56. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission.
Miura H; Miyachi Y
JOP; 2009 Jul; 10(4):432-7. PubMed ID: 19581751
[TBL] [Abstract][Full Text] [Related]
57. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.
Detlefsen S; Klöppel G
Virchows Arch; 2018 Apr; 472(4):545-556. PubMed ID: 29196804
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings.
Ozkavukcu E; Erden A; Erden I
Eur J Radiol; 2009 Apr; 70(1):118-21. PubMed ID: 18282675
[TBL] [Abstract][Full Text] [Related]
59. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
[TBL] [Abstract][Full Text] [Related]
60. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
